“vertex” Archives

Entry Author Date Location
Editor’s Picks: Xconomy Boston’s Top 20 Stories of 2010 12/27/10 Boston
Zogenix Goes Public, Amira Restructures, Apricus Gets Boost From FDA Agreement on Cancer Drug Trial, & More San Diego Life Sciences News 11/24/10 San Diego
Xconomy Boston’s Top 20 Stories of the Third Quarter: From A123 Expansion to Zynga Acquisition 10/01/10 Boston
Vertex Tops Merck 08/04/10 Boston
Vertex Pursues Drug-Cocktail Strategy, Phase Forward Out To Expand Health IT Empire, Alkermes Awaits FDA Ruling, & More Boston-Area Life Sciences News 03/12/10 Boston
A Graceful Exit for Gloucester, Pink Slips at Sermo, A Half a Billion Bucks for Vertex, & More Boston-Area Life Sciences News 12/09/09 Boston
Amylin Forms Global Alliance in Obesity Drug Development; TEDMED’s Show Will Go On, Sequenom Sued for Civil Fraud, & More San Diego Biotech News 11/05/09 San Diego
Merck Makes GlycoFi Center of its Biogenerics Strategy, Biogen Says Tysabri Might Promote Remyelination, Stemgent Teams with Fate, & More Boston-Area Life Sciences News 04/30/09 Boston
Let’s Talk About Tomorrow, People—at Next Week’s Xconomy Biotech Forum 04/24/09 Boston
Vertex Offering Up To $220M 09/22/08 Boston
Vertex Raises $191 Million in Stock Offering 09/18/08 Boston
Vertex To Sell 7 Million Shares of Stock 09/17/08 Boston
Vertex Fending Off Competitors By Treating the Toughest Patients With Hepatitis C 09/09/08 Boston
Vertex on the Rise, Sirtris on TV, an IPO (Finally) on the Table, and More Life Sciences News 04/02/08 Boston
Vertex Climbs on Encouraging Early Results From Cystic Fibrosis Drug Trial 03/27/08 Boston
Biogen Idec, Vertex, and Genzyme Try Different Ways to Skin the Innovation Cat 12/19/07 Boston
Page 2 of 2 « previous page